200 Most Common Drugs

200 Most Common Drugs Seminar (DRG1)

Full Course: (Expired for AGD PACE and ADA CERP recognition); 16 for California Board of Dental Examiners (CBDE) for CD/CPD Credits

Courses are appropriate for:  General Dentists, Oral Surgeons, Endodontists, Geriatric Dental Specialists, Dental Implant Surgeons, Prosthodontists, Dental Assistants and Dental Hygienists

200 Most Common Drugs (DRG1) Topics Include: Cardiovascular Drugs, Drugs for Thromboembolic Complications, Endocrine Drugs, Diabetes Medications, Thyroid Dysfunction, Adrenal Function, Osteopenia & Osteoporosis, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:
Full Course:
DRG1
Full Course Price:
$580
Format:
Available in Video format.
Only Available Option: Full

Instructor Bio

Dr. Geza Terezhalmy, DDS, MA

Biography

Dr. Geza T. Terezhalmy received his D.D.S. degree from Case Western Reserve School of Dental Medicine and his M.A. from The George Washington University. Currently he is a professor for the Department of Comprehensive Dentistry at the University of Texas Health Science Center at the San Antonio Dental School. He is also a clinical professor for the Department of Pharmacology at the Graduate School of Biomedical Sciences at the University of Texas Health Science Center at the San Antonio Dental School. Dr. Terezhalmy serves as a National Consultant for Dental Pharmacotherapeutics to the US Surgeon General and also to the Naval Postgraduate Dental School as a consultant in their department of Oral Medicine. He has served on the editorial boards of Quintessence International, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology and has an extensive list of publication credits with articles appearing in The American Journal of Dentistry, The International Journal of Dental Hygiene, the Journal of Contemporary Dental Practice and the Archives of Oral Biology. Dr. Terezhalmy has served as president of the Organization of Teachers of Oral Diagnosis and of the American Academy of Oral Medicine.

Conflict of Interest Disclosure: None reported

Topics

Introduction/Overview

Cardiovascular Drugs

Drugs for Hypertention

Drugs for Coronary Artery

Drugs for Cardiac Arrhythmias

Drugs for Heart Failure

Drugs for Thromboembolic Complications

Treatment Strategies

Endocrine Drugs

Diabetes Medications

Drugs for Thyroid Dysfunction

Drugs for Adrenal Function

Drugs for Osteopenia & Osteoporosis

Course Objective

COURSE OBJECTIVE

Today’s clinicians treat more medically and pharmacologically compromised patients than ever before. The availability of more than a thousand active ingredients in several thousand different formulations, and with over 100,000 nonprescription medications, with hundreds of facts about each of them, presents a seemingly insurmountable challenge in mastering the essentials for the clinical decision making process. Fortunately, the clinician who understands general pharmacological principles can learn to predict the behavior of each drug based on a few facts. It is better to develop a drug profile than it is to memorize isolated data. The best way to achieve this objective is to associate, envision, predict, and inquire.

  • Associate each drug with information already know
  • Envision the course of events that would occur as a drug enters the patient’s body
  • Predict clinical uses and adverse drug effects based on a drug’s mechanism of action
  • Inquire which fact about a drug is going to impact on the clinical decision making process

GENERAL OBJECTIVES

Participants in this course will be introduced to representative cardiovascular drug profiles based on the top 200 drugs dispensed by U.S. community pharmacies. An awareness of the various drugs commonly prescribed drugs will assist clinicians in identifying patients with commonly encountered cardiovascular problems. The intent is to provide participants with evidence-based knowledge essential for risk stratification of patients taking cardiovascular drugs and the development of appropriate diagnostic, preventive, and therapeutic strategies commensurate with a patient’s ability to undergo and respond to dental care.

LEARNING OUTCOMES

After completing this course the participant will have a better understanding and working knowledge of the following:

  • Evidence-based knowledge essential for risk stratifications of patients taking one of 200 drugs dispensed by United States community pharmacies and for the developing oral healthcare strategies commensurate with patients’ functional capacity
  • Discuss the medical management of common systemic diseases predicated on the top 200 prescription drugs
  • Discuss disease-related, treatment-related and procedure-related variables
  • Develop therapeutic strategies predicated on the patient’s ability to undergo and respond to dental care

Accreditation

American Seminar Institute is an approved provider of ADA-CERP, AGD-PACE and the California Board of Dental Examiners.
 
 

                                                                                                           

California Board of Dental Examiners (CBDE)

American Seminar Institute is an approved provider for the California Board of Dental Examiners, License# 2068.

Credits satisfy California Dental Education Requirements, as well as most State and Dental Academy requirements.

                                                                                                           

Because each individual agency/academy/state has specific requirements, it is necessary that you consult with the

appropriate agency/academy/state regarding final approval of continuing education credits.

Produced: 4/01/2014      Expires for AGD Credit: 3/31/2017

 

 

 

Additional Information

Additional Dental Continuing Education (CE/CPD) options available:

Other courses of interest may include:  Dental Pharmacology, Infection Control, Local Anesthesia and Nitrous Oxide Sedation

For up-coming courses, please visit: Dental Courses Coming Soon There you will find abbreviated listings of additional courses that are soon to be released.